NEW YORK & LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Rodman & Renshaw (NASDAQ: RODM) and BioSante (NASDAQ: BPAX) today announced that Rodman will host Stephen M. Simes, CEO of BioSante Pharmaceuticals, for a fireside chat in Rodman’s media center, on March 24, 2010. The event will be moderated by Elemer Piros, Ph.D., senior biotechnology analyst at Rodman & Renshaw, LLC. The topics to be covered will include an overview of BioSante and specifically LibiGel® (testosterone gel) in development for the treatment of female sexual dysfunction, as well as BioSante’s portfolio of cancer vaccines.
